Embrionary way to create a fatty liver in portal hypertension
暂无分享,去创建一个
M. Aller | N. Arias | J. Arias | J. Arias | I. Peral | Sara García-Higarza | Jaime Arias | Natalia Arias | Isabel Peral | Sara García-Higarza
[1] P. Newsome,et al. Non-alcoholic fatty liver disease in 2016. , 2016, British medical bulletin.
[2] Lynne Pearce,et al. Non-alcoholic fatty liver disease. , 2016, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[3] S. Hollenberg,et al. The Circulatory System in Liver Disease. , 2016, Critical care clinics.
[4] F. Chisari,et al. Immunosurveillance of the Liver by Intravascular Effector CD8+ T Cells , 2015, Cell.
[5] R. Moreau,et al. Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. , 2015, Journal of hepatology.
[6] R. Groszmann,et al. Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments. , 2015, Journal of hepatology.
[7] Kazuaki Chayama,et al. Nonalcoholic fatty liver disease and cardiovascular disease. , 2014, Current pharmaceutical design.
[8] L. Liaudet,et al. The role of oxidative stress during inflammatory processes , 2013, Biological chemistry.
[9] N. Wiernsperger. Hepatic function and the cardiometabolic syndrome , 2013, Diabetes, metabolic syndrome and obesity : targets and therapy.
[10] J. Breuss,et al. Cold induces reactive oxygen species production and activation of the NF‐kappa B response in endothelial cells and inflammation in vivo , 2013, Journal of thrombosis and haemostasis : JTH.
[11] P. García-Rovés,et al. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: Cause or consequence? , 2013, Free radical research.
[12] G. Tarantino,et al. What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? , 2013, World journal of gastroenterology.
[13] H. Nishina,et al. The expanding role of fish models in understanding non-alcoholic fatty liver disease , 2013, Disease Models & Mechanisms.
[14] D. Häussinger,et al. Hepatic stem cell niches. , 2013, The Journal of clinical investigation.
[15] Y. Nie,et al. Association between metabolic syndrome and the development of non-alcoholic fatty liver disease , 2013, Experimental and therapeutic medicine.
[16] A. Caraffa,et al. Vascular Endothelial Growth Factor (VEGF), Mast Cells and Inflammation , 2013, International journal of immunopathology and pharmacology.
[17] M. Michalska,et al. Influence of Block of NF-Kappa B Signaling Pathway on Oxidative Stress in the Liver Homogenates , 2013, Oxidative medicine and cellular longevity.
[18] M. Aller,et al. Surgical inflammatory stress: the embryo takes hold of the reins again , 2013, Theoretical Biology and Medical Modelling.
[19] C. Hellerbrand. Hepatic stellate cells—the pericytes in the liver , 2013, Pflügers Archiv - European Journal of Physiology.
[20] M. Aller,et al. The risk association between experimental portal hypertension and an aortic atherosclerosis‐like disease , 2013, Hepatology.
[21] Michael T Longaker,et al. Soft tissue mechanotransduction in wound healing and fibrosis. , 2012, Seminars in cell & developmental biology.
[22] M. Aller,et al. Portal hypertension-related inflammatory phenotypes: From a vitelline and amniotic point of view , 2012 .
[23] J. García‐Pagán,et al. Functional aspects on the pathophysiology of portal hypertension in cirrhosis. , 2012, Journal of hepatology.
[24] M. Aller,et al. The wound‐healing response and upregulated embryonic mechanisms: brothers‐in‐arms forever , 2012, Experimental dermatology.
[25] J. Regadera,et al. A wound-like inflammatory aortic response in chronic portal hypertensive rats. , 2012, Molecular immunology.
[26] Y. Soejima,et al. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. , 2012, World journal of gastroenterology.
[27] G. Kanel,et al. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. , 2012, Gastroenterology.
[28] Kazuo Tanishita,et al. Spatio-temporal control of hepatic stellate cell-endothelial cell interactions for reconstruction of liver sinusoids in vitro. , 2012, Tissue engineering. Part A.
[29] M. Aller,et al. Portal hypertensive cardiovascular pathology: the rescue of ancestral survival mechanisms? , 2012, Clinics and research in hepatology and gastroenterology.
[30] G. Parker,et al. Immune Functioning in Non lymphoid Organs: The Liver , 2012, Toxicologic pathology.
[31] Richard A. Flavell,et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.
[32] Giorgio Saracco,et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study , 2011, Hepatology.
[33] J. Newton,et al. Autonomic dysfunction in chronic liver disease , 2011, Hepatic medicine : evidence and research.
[34] Guojun Sheng,et al. Yolk sac endoderm is the major source of serum proteins and lipids and is involved in the regulation of vascular integrity in early chick development , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.
[35] Jonathan C. Cohen,et al. Human Fatty Liver Disease: Old Questions and New Insights , 2011, Science.
[36] M. Nalls,et al. Associations of Visceral and Liver Fat With the Metabolic Syndrome Across the Spectrum of Obesity: The AGES‐Reykjavik Study , 2011, Obesity.
[37] A. David,et al. Clinical applications of prenatal and postnatal therapy using stem cells retrieved from amniotic fluid , 2011, Current opinion in obstetrics & gynecology.
[38] M. Aller,et al. Gut-Brain Chemokine Changes in Portal Hypertensive Rats , 2011, Digestive Diseases and Sciences.
[39] S. Coulon,et al. Angiogenesis in chronic liver disease and its complications , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[40] D. Thabut,et al. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? , 2010, Journal of hepatology.
[41] Enzo Bonora,et al. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.
[42] M. Aller,et al. Pathological axes of wound repair: Gastrulation revisited , 2010, Theoretical Biology and Medical Modelling.
[43] I. Weissman,et al. The origin and fate of yolk sac hematopoiesis: application of chimera analyses to developmental studies. , 2010, The International journal of developmental biology.
[44] M. Aller,et al. Partial hepatectomy, partial portal vein stenosis and mesenteric lymphadenectomy increase splanchnic mast cell infiltration in the rat. , 2010, Acta histochemica.
[45] W. Payne,et al. Amnion-Derived Cellular Cytokine Solution (ACCS) Promotes Migration of Keratinocytes and Fibroblasts , 2010, Annals of plastic surgery.
[46] C. Tseng,et al. Isolation of Mesenchymal Stem Cells with Neurogenic Potential from the Mesoderm of the Amniotic Membrane , 2010, Cells Tissues Organs.
[47] C. Cray,et al. Acute phase response in animals: a review. , 2009, Comparative medicine.
[48] D. Häussinger,et al. The niche of stellate cells within rat liver , 2009, Hepatology.
[49] M. Pinzani,et al. Hepatic wound repair , 2009, Fibrogenesis & tissue repair.
[50] M. Baron,et al. Embryonic fates for extraembryonic lineages: New perspectives , 2009, Journal of cellular biochemistry.
[51] M. Tufail,et al. Molecular characteristics of insect vitellogenins. , 2008, Journal of insect physiology.
[52] M. Aller,et al. Microsurgery in Liver Research , 2008 .
[53] F. Poordad,et al. Review article: diagnosis and treatment of non‐alcoholic fatty liver disease , 2008, Alimentary pharmacology & therapeutics.
[54] A. Freilinger,et al. Human amniotic fluid stem cells: a new perspective , 2008, Amino Acids.
[55] Y. Ohtani,et al. Lymph Circulation in the Liver , 2008, Anatomical record.
[56] A. Geerts,et al. Regulation of Sinusoidal Perfusion in Portal Hypertension , 2008, Anatomical record.
[57] Jia Luo,et al. Acute stretch promotes endothelial cell proliferation in wounded healing mouse skin , 2008, Archives of Dermatological Research.
[58] J. McDougall,et al. Central neural activation of hyperdynamic circulation in portal hypertensive rats depends on vagal afferent nerves , 2008, Gut.
[59] M. Yeh,et al. Pathology of nonalcoholic fatty liver disease. , 2007, American journal of clinical pathology.
[60] M. Aller,et al. The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension , 2007, Journal of Translational Medicine.
[61] M. Aller,et al. Hepatic lipid metabolism changes in short- and long-term prehepatic portal hypertensive rats. , 2006, World journal of gastroenterology.
[62] C. Bellini,et al. Lymphodynamics in the fetus and newborn. , 2006, Lymphology.
[63] M. Mejías,et al. Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats. , 2006, Journal of hepatology.
[64] D. Ingber,et al. Cellular mechanotransduction: putting all the pieces together again , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[65] E. Rondonotti,et al. Portal hypertensive enteropathy. , 2006, Gastrointestinal endoscopy clinics of North America.
[66] 寺田 周美. Transfer of maternal cholesterol to embryo and fetus in pregnant mice , 2006 .
[67] R. Groszmann,et al. The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule , 2006, Hepatology.
[68] C. Puoti,et al. Steatosis and portal hypertension. , 2005, European review for medical and pharmacological sciences.
[69] M. Aller,et al. Prehepatic portal hypertension produces increased mast cell density in the small bowel and in mesenteric lymph nodes in the rat , 2005, Journal of gastroenterology and hepatology.
[70] J. Rodés,et al. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. , 2005, Journal of hepatology.
[71] Titiz Izzet,et al. Oxidative stress in portal hypertension-induced rats with particular emphasis on nitric oxide and trace metals. , 2005, World journal of gastroenterology.
[72] M. Aller,et al. Tumor Necrosis Factor-α, Interleukin-1β and Nitric Oxide: Induction of Liver Megamitochondria in Prehepatic Portal Hypertensive Rats , 2005, World Journal of Surgery.
[73] M. Alonso,et al. Progressive hepatocytic fatty infiltration in rats with prehepatic portal hypertension. , 2005, Hepato-gastroenterology.
[74] M. Aller,et al. Posttraumatic Inflammation is a Complex Response Based on the Pathological Expression of the Nervous, Immune, and Endocrine Functional Systems , 2004, Experimental biology and medicine.
[75] Anders Goksøyr,et al. Eggshell and egg yolk proteins in fish: hepatic proteins for the next generation: oogenetic, population, and evolutionary implications of endocrine disruption , 2003, Comparative hepatology.
[76] K. Sharkey,et al. Hyperdynamic circulation in portal‐hypertensive rats is dependent on central c‐fos gene expression , 2002, Hepatology.
[77] E. Jauniaux,et al. Nutrition of the human fetus during the first trimester--a review. , 2001, Placenta.
[78] M. Aller,et al. Increased Duodenal Mucosa Infiltration by Mast Cells in Rats with Portal Hypertension , 2001, Digestive Surgery.
[79] E. Jauniaux,et al. Fluid compartments of the embryonic environment. , 2000, Human reproduction update.
[80] D. Carnall. Risk of cardiovascular disease , 2000, BMJ : British Medical Journal.
[81] K. Kaneda,et al. Phenotypical and morphological alterations to rat sinusoidal endothelial cells in arterialized livers after portal branch ligation. , 1999, Archives of histology and cytology.
[82] I. Kushner,et al. Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.
[83] E. Jauniaux,et al. Protein and enzyme patterns in the fluid cavities of the first trimester gestational sac: relevance to the absorptive role of secondary yolk sac. , 1998, Molecular human reproduction.
[84] C. Day,et al. Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.
[85] C. Gostout,et al. Portal hypertensive intestinal vasculopathy: a review of the clinical, endoscopic, and histopathologic features. , 1992, The American journal of gastroenterology.
[86] Vicente Arroyo,et al. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis , 1988, Hepatology.
[87] W W Lautt,et al. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. , 1985, The American journal of physiology.
[88] H. Popper,et al. Capillarization of hepatic sinusoids in man. , 1963, Gastroenterology.
[89] S. Chien,et al. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. , 2011, Physiological reviews.
[90] E. Bevilacqua,et al. Trophoblast phagocytic program: roles in different placental systems. , 2010, The International journal of developmental biology.
[91] S. Friedman. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.
[92] M. Aller,et al. Lipids in Health and Disease , 2008 .
[93] M. Aller,et al. Tumor necrosis factor-alpha, interleukin-1beta and nitric oxide: induction of liver megamitochondria in prehepatic portal hypertensive rats. , 2005, World journal of surgery.
[94] W. Collins,et al. Relationship between protein concentrations in embryological fluids and maternal serum and yolk sac size during human early pregnancy. , 1994, Human reproduction.
[95] M. Aller,et al. Theoretical Biology and Medical Modelling Open Access Inflammation: a Way to Understanding the Evolution of Portal Hypertension , 2022 .